| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Carcinogenesis |
Laboratory of Radiation and Life Science, Department of Health Sciences, School of Pharmaceutical Sciences, Nagasaki University, Nagasaki 852-8521, Japan
We demonstrated here that X-ray irradiation at very low doses of between 2 and 5 cGy stimulated proliferation of normal human diploid cells and human tumor cells. Higher doses of irradiation at >1 Gy accumulated p53 protein and induced phosphorylation of extracellular signal-regulated kinase (ERK) 1/2. Phosphorylation of ERK1/2 decreased with dose down to 50 cGy, however, doses of between 5 cGy and 2 cGy phosphorylated ERK1/2 as efficiently as higher doses of X-rays, whereas the p53 protein level was not changed by doses <50 cGy. We found that mitogen-activated protein /ERK kinase (MEK) 1 was phosphorylated with both 2 cGy and 6 Gy of X-rays, and that activated ERK1/2 augmented phosphorylation of Elk-1 protein. The specific epidermal growth factor receptor tyrosine kinase inhibitor, AG1478, decreased phosphorylation of the ERK1/2 proteins induced by 2 cGy or 6 Gy of X-rays, and similar suppressive effect was observed with MEK inhibitor, PD98059. Suppression of ERK1/2 phosphorylation with these inhibitors alleviated enhanced proliferation of normal human cells by low-dose irradiation. Furthermore, overexpression of ERK2 in NCI-H1299 human lung carcinoma cells potentiated enhanced proliferation, whereas down-regulation of ERK2 using the antisense ERK2 gene abrogated the stimulative effect of low-dose irradiation. These results indicate that a limited range of low-dose ionizing radiation differentially activates ERK1/2 kinases via activation of epidermal growth factor receptor and MEK, which causes enhanced proliferation of cells receiving very low doses of ionizing radiation.
This article has been cited by other articles:
|
|
 |
|
  Y. Miura, M. Kano, M. Yamada, T. Nishine, S. Urano, S. Suzuki, T. Endo, and T. Toda Proteomic Study on X-irradiation-responsive Proteins and Ageing: Search for Responsible Proteins for Radiation Adaptive Response J. Biochem., August 1, 2007; 142(2): 145 - 155. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Fan, K. M. Ahmed, M. C. Coleman, D. R. Spitz, and J. J. Li Nuclear Factor-{kappa}B and Manganese Superoxide Dismutase Mediate Adaptive Radioresistance in Low-Dose Irradiated Mouse Skin Epithelial Cells Cancer Res., April 1, 2007; 67(7): 3220 - 3228. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. Ahmed, S. Dong, M. Fan, and J. J. Li Nuclear Factor-{kappa}B p65 Inhibits Mitogen-Activated Protein Kinase Signaling Pathway in Radioresistant Breast Cancer Cells Mol. Cancer Res., December 1, 2006; 4(12): 945 - 955. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. Pelloski, E Lin, L. Zhang, W.K. A. Yung, H. Colman, J.-L. Liu, S. Y. Woo, A. B. Heimberger, D. Suki, M. Prados, et al. Prognostic Associations of Activated Mitogen-Activated Protein Kinase and Akt Pathways in Glioblastoma. Clin. Cancer Res., July 1, 2006; 12(13): 3935 - 3941. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K N Prasad Rationale for using multiple antioxidants in protecting humans against low doses of ionizing radiation Br. J. Radiol., June 1, 2005; 78(930): 485 - 492. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Wang, Y.-C. Hu, S. Dong, M. Fan, D. Tamae, M. Ozeki, Q. Gao, D. Gius, and J. J. Li Co-activation of ERK, NF-{kappa}B, and GADD45{beta} in Response to Ionizing Radiation J. Biol. Chem., April 1, 2005; 280(13): 12593 - 12601. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. W. Caron, A. Yacoub, X. Zhu, C. Mitchell, S. I. Han, T. Sasazuki, S. Shirasawa, M. P. Hagan, S. Grant, and P. Dent H-RAS V12-induced radioresistance in HCT116 colon carcinoma cells is heregulin dependent Mol. Cancer Ther., February 1, 2005; 4(2): 243 - 255. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. W. Caron, A. Yacoub, M. Li, X. Zhu, C. Mitchell, Y. Hong, W. Hawkins, T. Sasazuki, S. Shirasawa, A. P. Kozikowski, et al. Activated forms of H-RAS and K-RAS differentially regulate membrane association of PI3K, PDK-1, and AKT and the effect of therapeutic kinase inhibitors on cell survival Mol. Cancer Ther., February 1, 2005; 4(2): 257 - 270. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. I. S. Rattan The Future of Aging Interventions: Aging Intervention, Prevention, and Therapy Through Hormesis J. Gerontol. A Biol. Sci. Med. Sci., July 1, 2004; 59(7): B705 - B709. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. N. Prasad, W. C. Cole, and G. M. Hasse Health Risks of Low Dose Ionizing Radiation in Humans: A Review Experimental Biology and Medicine, May 1, 2004; 229(5): 378 - 382. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Hamada, S. Kodama, K. Suzuki, and M. Watanabe Gap junctional intercellular communication and cellular response to heat stress Carcinogenesis, November 1, 2003; 24(11): 1723 - 1728. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Chen, K. Alm, S. Vujcic, D. L. Kramer, K. Kee, P. Diegelman, and C. W. Porter The Role of Mitogen-activated Protein Kinase Activation in Determining Cellular Outcomes in Polyamine Analogue-treated Human Melanoma Cells Cancer Res., July 1, 2003; 63(13): 3619 - 3625. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Nishino, C. D. Pusey, and J. Domin Elevated Akt Phosphorylation as an Indicator of Renal Tubular Epithelial Cell Stress J. Biol. Chem., September 6, 2002; 277(37): 33943 - 33949. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Edwards, L. Geng, J. Tan, H. Onishko, E. Donnelly, and D. E. Hallahan Phosphatidylinositol 3-Kinase/Akt Signaling in the Response of Vascular Endothelium to Ionizing Radiation Cancer Res., August 15, 2002; 62(16): 4671 - 4677. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |
